LBank Announces a Blockbuster Roadshow to Facilitate Web3 and Crypto Adoption

DUBAI, UAE / ACCESSWIRE / June 28, 2023 / LBank, a global digital asset trading platform, is set to embark on an exciting educational initiative to enhance cryptocurrency awareness in key regions worldwide. The ‘LBank Roadshow,’ a series of events, will be held in seven major cities, spanning June to August. As part of the […]

DUBAI, UAE / ACCESSWIRE / June 28, 2023 / LBank, a global digital asset trading platform, is set to embark on an exciting educational initiative to enhance cryptocurrency awareness in key regions worldwide. The ‘LBank Roadshow,’ a series of events, will be held in seven major cities, spanning June to August. As part of the broader LBank events, the LBank Roadshow focuses explicitly on fostering the development of the thriving blockchain and crypto ecosystems in India, Seoul, Bangkok, Manila, Dubai, Kuala Lumpur, Istanbul, and Tokyo. By empowering and inspiring younger generations to embrace Web3 and leverage crypto tools, this initiative seeks to propel the adoption and understanding of these transformative technologies.

Innovation serves as a fundamental driving force for any team or projects striving to maintain a competitive edge, particularly in the realm of Web3. Its significance cannot be underestimated. However, even with seminal ideas, their potential can remain unrealized if they aren’t shared with the appropriate audience. This is precisely where LBank steps in. Introducing the LBank Roadshow, a collection of complimentary one-day events designed to provide traders, crypto enthusiasts, developers, and builders worldwide with workshops and panel discussions. The Roadshow presents an exceptional opportunity to acquire fresh Web3 skills, gain visibility, forge valuable connections, and propel your innovative ventures to new heights.

LBank recognizes the vital role played by crypto enthusiasts in nurturing the web3 ecosystem. To cater to their needs and provide an enriching experience, we have curated a remarkable series of events. Immerse yourself in a range of captivating activities, such as enlightening educational sessions, stimulating panel discussions, captivating keynote speeches, and invaluable networking opportunities with fellow passionate individuals who share your interests.

LBank CEO, Allen Wei said, “We are committed to empowering the growth and prosperity of our listed projects, and our roadshow events provide an ideal platform to enhance their market impact. These events offer a unique opportunity for attendees to engage with potential investors, developers, partners, and users while immersing themselves in the thriving crypto communities of these cities.”

He further stated: “As we establish our global presence through the ‘Web3 Connect’ Roadshow events, we strive to lead the way in driving positive change within the crypto world.”

Registrations for the Roadshow will be strictly curated so that we assemble high-quality cohorts at each event. Registration also comes with an amazing affiliate program and promotional offers.

Promotional Offers
To expand its influence and gain more substantial support from the cryptocurrency community, LBank is introducing enticing incentives for traders on its platform. Users now have the chance to earn bonuses while also being invited to participate in an enriching affiliate program.

As a gesture of goodwill, LBank is granting new users the exclusive privilege of testing the platform with a live account that comes pre-funded with a registration bonus. Adding to the excitement, all new users will also receive a daily trading bonus. To claim this bonus, new users simply need to follow us.

Through LBank’s Affiliate Program, users have the potential to earn impressive commissions of up to 50% from direct traffic, including Maker Fees payments. Additionally, indirect traffic generated through sub-affiliates offers an extra 20% in commissions. This presents a remarkable opportunity for cryptocurrency enthusiasts to capitalize on one of the most outstanding affiliate programs available in the industry, enabling them to potentially earn a substantial income.

Community & Social Media: Telegram l Twitter l Facebook l Linkedin

Contact Details:

Abhinav Mehta
LBK Blockchain Co. Limited
media@lbank.info

SOURCE: LBank

IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate

NEW YORK, NY / ACCESSWIRE / June 27, 2023 / IAVI announced today that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase I clinical trial in the U.S. The IAVI-sponsored trial is funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration […]

NEW YORK, NY / ACCESSWIRE / June 27, 2023 / IAVI announced today that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase I clinical trial in the U.S. The IAVI-sponsored trial is funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).

Known as IAVI C108, this first-in-human study is designed to evaluate the safety and immunogenicity of an investigational SUDV vaccine candidate donated to IAVI by Merck (known as MSD outside the U.S. and Canada) to supplement IAVI’s ongoing SUDV vaccine development program. This investigational SUDV vaccine candidate was produced for IAVI from existing investigational bulk drug substance previously manufactured by Merck. IAVI is the vaccine candidate’s regulatory sponsor. IAVI is responsible for all aspects of the candidate’s future development, including demonstrating equivalence between this SUDV vaccine candidate and IAVI’s other SUDV vaccine candidate, which utilizes the same viral vector but is manufactured using a new production platform.

The SUDV vaccine candidate being evaluated in IAVI C108 uses the same recombinant vesicular stomatitis virus (rVSV) viral vector platform as ERVEBO®, Merck’s single-dose Zaire ebolavirus (ZEBOV) vaccine which is licensed in the U.S., U.K., European Union, Canada, Switzerland, and 10 African countries. rVSV is also the platform technology utilized in IAVI’s portfolio of emerging infectious disease (EID) candidates.

“IAVI C108 represents an important first step toward generating the data needed for eventual licensure of an rVSV-SUDV vaccine. The development and licensure of ERVEBO® has resulted in an important tool in Ebola Zaire outbreak response. If proven effective, we’re hopeful that a vaccine candidate built on the same viral platform will be similarly important in future SUDV outbreaks,” said Swati Gupta, Ph.D., vice president and head of emerging infectious diseases and epidemiology at IAVI. “In parallel, we must continue accelerating efforts toward the adequate availability of candidate vaccine doses for evaluation during and ahead of outbreaks with key partners, collaborators, and funders. We’re grateful to Merck for donating the doses that will be used in IAVI C108 and to BARDA for its support of this trial.”

IAVI C108 will take place at two U.S.-based clinical trial sites, where the study vaccine will be administered intramuscularly at three dosage levels. This is a placebo-controlled, single-blind study, meaning that only the researchers conducting the study will know whether a participant has received a vaccine dose or a placebo dose until after the trial is over. Approximately 36 healthy adults will be enrolled and will be followed for six months after vaccination to monitor their safety and immune responses to the vaccine candidate.

Like ZEBOV, SUDV is responsible for recurring viral hemorrhagic fever outbreaks, which have had lasting impacts on health security and geopolitical stability across sub-Saharan Africa. The estimated case fatality ratios of SUDV disease have varied from 41% to 100% in past outbreaks[1]. Despite high morbidity and mortality, there are no vaccines or therapeutics licensed for the prevention and treatment of SUDV. Existing ZEBOV vaccines and treatments are not effective against SUDV. Data being generated from ongoing studies suggest that rVSV could be a safe and effective platform for responding to SUDV and other related pathogens[2].

IAVI’s rVSV-based EID portfolio includes a SUDV vaccine candidate supported by BARDA; a Lassa fever virus vaccine candidate currently in a Phase I trial and supported by the Coalition for Epidemic Preparedness Innovations and the European & Developing Countries Clinical Trials Partnership; a Marburg virus vaccine candidate supported by BARDA and the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DOD); and an intranasal SARS-CoV-2 vaccine candidate supported by DOD DTRA and the Japan Ministry of Finance.

The rVSV platform has been used extensively in adults and children[3]. The underlying vesicular stomatitis virus (VSV) is a common animal virus that does not cause serious illness in humans and has been investigated extensively as a vaccine vector. In the vaccine platform, it is engineered to encode a surface protein from a target pathogen – in this case, SUDV – to prompt the body to mount an immune response.

Much of the research and development on IAVI’s rVSV platform is performed at the IAVI Vaccine Design and Development Lab (DDL) in Brooklyn, New York. The DDL is located at the bioscience center in the historic Brooklyn Army Terminal. Since its founding in 2008, the IAVI DDL has become one of the world’s leading viral vector vaccine research and development labs, known for innovation and generation of novel vaccine design concepts.

Scientists with IAVI’s Human Immunology Laboratory (HIL) in London, U.K., are involved in processing participant samples and developing the analytical assays needed to evaluate IAVI C108 participants’ immune responses. Established in 2001, the HIL is fully integrated into the Infectious Disease department within the Faculty of Medicine at Imperial College London and serves as the clinical immunology reference laboratory for IAVI and the network of clinical research centers with which IAVI collaborates worldwide.

Media Contact
Rose Catlos
Rcatlos@iavi.org
212-847-1049

About IAVI
IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV, tuberculosis, and emerging infectious diseases. Its mission is to translate scientific discoveries into affordable, globally accessible public health solutions. Read more at iavi.org.

Follow IAVI on Facebook, LinkedIn, Instagram, and YouTube, and subscribe to our news updates.

About IAVI’s rVSV vaccine candidates
IAVI holds a nonexclusive license to the rVSV vaccine candidates from the Public Health Agency of Canada (PHAC). The vector was developed by scientists at PHAC’s National Microbiology Laboratory.

IAVI initially developed its rVSV vector for HIV vaccine candidates and has since expanded its use to the development of vaccines addressing emerging infectious diseases (Lassa Fever, Marburg, Sudan ebolavirus, and COVID-19).

Funders who have made the development of IAVI’s rVSV-vectored vaccine candidates possible include the Bill & Melinda Gates Foundation; the Government of Canada; the Danish Ministry of Foreign Affairs; the Government of Japan; the Irish Department of Foreign Affairs and Trade; the Netherlands Ministry of Foreign Affairs; the Norwegian Agency for Development Cooperation; the U.K Department for International Development; the U.S. National Institutes of Health; and through the generous support of the American people from the United States Agency for International Development.

This project is funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority under contract number 75A50121C00077.

[1] https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON410

[2] https://link.springer.com/article/10.1007/s11262-017-1455-x

[3] https://cdn.who.int/media/docs/default-source/blue-print/who-vaccine-prioritization-report-uganda-ebola-trial-nov-16-2022.pdf

SOURCE: IAVI

South Africa’s “Oasis (Reach for Your Dreams)” Receives Recognition from UNAOC-BMW Group’s Intercultural Innovation Hub

BERLIN, GERMANY / ACCESSWIRE / May 25, 2023 / South African organization “Oasis: `Reach For Your Dreams`” is one of ten global grassroots recognized by the prestigious Intercultural Innovation Hub, a joint initiative of the United Nations Alliance of Civilizations (UNAOC) and the BMW Group, implemented with the support of Accenture, during a ceremony held […]

BERLIN, GERMANY / ACCESSWIRE / May 25, 2023 / South African organization “Oasis: `Reach For Your Dreams`” is one of ten global grassroots recognized by the prestigious Intercultural Innovation Hub, a joint initiative of the United Nations Alliance of Civilizations (UNAOC) and the BMW Group, implemented with the support of Accenture, during a ceremony held in Berlin, Germany.

Selected for their project “Community Street Football/Netball”, the organization leverages the role of sport to help youth who have fallen through the gaps within society, and have either dropped out of school or have become involved in gang-related activities, by supporting their reintegration into society and empowering them to lead positive and self-sufficient lives. The programme engages participants in street football events, while uplifting young people by instilling them with life skills based on the values inherent to sports, such as team spirit, fair play, respect, and conflict management.

“We are honored to receive the support of the Intercultural Innovation Hub in addressing the challenges of the youth in our communities, and providing alternative solutions for their positive growth,” said Clifford Martinus, Founder of “Oasis `Reach For Your Dreams`”.

Every year, the Intercultural Innovation Hub supports grassroots initiatives that promote intercultural dialogue and understanding, thereby contributing to peace, cultural diversity, and more inclusive societies. This year, the Ceremony was chaired by Mr. Miguel Ángel Moratinos, United Nations Under-Secretary-General and the High Representative for UNAOC, and Ms. Ilka Horstmeier, Member of the Board of Management of BMW AG People and Real Estate, Labour Relations Director.

Through the Intercultural Innovation Hub, Oasis `Reach For Your Dreams` will receive a financial grant, as well as one year of capacity-building and mentorship support from UNAOC, the BMW Group, and Accenture to help strengthen the “Community Street Football/Netball” project and its contribution towards a more inclusive society. This model of collaboration between the United Nations and the private sector creates a more profound impact, as partners provide their respective expertise to ensure the sustainable growth of each supported project.

Learn more about the project:

https://interculturalinnovation.org/oasis-reach-for-your-dreams-community-street-football-netball/

Media Inquiries:

Milena Pighi, Head of Corporate Social Responsibility, BMW Group, Milena.PA.Pighi@bmw.de
Alessandro Girola, Programming Coordinator, UNAOC, alessandrog@unops.org

SOURCE: United Nations Alliance of Civilizations (UNAOC)

Encryptus Unveils the Largest Payout Network at Coindesk Consensus

LITHUANIA, EUROPE / ACCESSWIRE / May 8, 2023 / Encryptus, a leading cryptocurrency solutions provider, announced during Coindesk’s Consensus event the launch of industry leading payout product, which allows crypto exchanges, wallet providers, Web3, Gaming and other B2C crypto companies to off-ramp to Bank Wires, Mobile Wallets, Mobile Top-ups and Gift Cards with API’s.The payout […]

LITHUANIA, EUROPE / ACCESSWIRE / May 8, 2023 / Encryptus, a leading cryptocurrency solutions provider, announced during Coindesk’s Consensus event the launch of industry leading payout product, which allows crypto exchanges, wallet providers, Web3, Gaming and other B2C crypto companies to off-ramp to Bank Wires, Mobile Wallets, Mobile Top-ups and Gift Cards with API’s.The payout network has coverage in 79 Countries for Bank Wires in 41 currencies, 39 countries for Mobile Wallets and 115+ countries for mobile top ups and gift cards. There are over 7,500 different types of gift cards and prepaid airtime of 307 Mobile operators globally available with Encryptus’s payouts. Popular Mobile Wallets like AliPay, GoCash and M-Pesa are among the few available.

As part of its commitment to regulatory compliance, Encryptus does not provide off ramps to sanctioned countries and clients. In addition the services are not available to residents and citizens of the US, Canada and Japan due to the regulatory landscape. The payout product is particularly beneficial for users looking to cash out crypto to fiat (national currencies) to their own bank accounts or purchase gift cards or mobile plans in over 100 countries. The payouts combined will be available in 98 currencies. The services are available via APIs but the company will unveil their widget soon.

Encryptus’ payout product is fully automated, with compliance monitoring tools to identify PEP and Sanctioned users and dirty coins via coin monitoring being integrated into its APIs.

“We are excited to launch our payouts; QuickRemit. Our payout network is not just the largest but offers the widest form of payments in the crypto industry. The API offers payout as a service and also keeps compliance as a core offering. Our vision is to further expand our payout coverage with a commitment to reduce the costs of payouts for the users” said Shantnoo Saxsena, CEO of Encryptus.

Shantnoo further explained that true crypto adoption will not happen with good pay-in networks, but with an extension to multiple payouts. Exchanges and crypto companies must not just focus on bringing users to their platform, but they must offer their users enough freedom to cash out.

Encryptus has aggressively priced the global bank wires for a flat fee of 1.5% and have a revenue share reserve from this amount for their partners. The accepted crypto would only be USDT and USDC.

The company promises to simplify global mobile wallet payouts and business payments in the upcoming upgrade.

Overall, the launch of the new payout product by Encryptus represents a significant milestone in the evolution of blockchain-based payments solutions. The need of the hour is to provide a secure, automated, and affordable way to off-ramp crypto holdings into various forms of payments. Encryptus is helping to further expand the adoption of cryptocurrencies and drive innovation in the fintech industry.

Twitter: https://twitter.com/EncryptusGlobal
LinkedIn: https://www.linkedin.com/company/encryptus/
Website: https://encryptus.io/

Please free to contact Abhi@encryptus.io for any queries.

SOURCE: Encryptus

LBank to Participate in the Inaugural Web3 Festival in Hong Kong

DUBAI, UAE / ACCESSWIRE / April 15, 2023 / LBank, a top cryptocurrency exchange, is proud to announce its participation in the inaugural Web3 Festival taking place from April 12-15 at the Hong Kong Convention and Exhibition Centre (HKCEC). The festival is co-hosted by Wanxiang Blockchain Labs and HashKey Group and organized by W3ME.The event […]

DUBAI, UAE / ACCESSWIRE / April 15, 2023 / LBank, a top cryptocurrency exchange, is proud to announce its participation in the inaugural Web3 Festival taking place from April 12-15 at the Hong Kong Convention and Exhibition Centre (HKCEC). The festival is co-hosted by Wanxiang Blockchain Labs and HashKey Group and organized by W3ME.The event promises to be an exciting four-day gathering of thousands of attendees, featuring hundreds of distinguished industry speakers, Web3 projects, community partners and media partners from around the world. With five center stages spread across an area of about 9,000㎡, the festival will provide a unique opportunity for attendees to network, share, and learn through high-level content and panel discussions.

At the Web3 Festival, LBank will have the opportunity to showcase its innovative cryptocurrency trading platform and engage with industry leaders and participants. The festival aims to bring together the world’s brightest minds, top Web3 projects and leading venture capitals, presenting content-rich discussions and topics centered around Web3. The festival will also feature regulatory representatives from Hong Kong who will dive into and interpret the latest digital asset regulation policies.

In addition, attendees should get ready for an evening of unforgettable experiences as LBank presents the AfterParty, called LBank Friday Crypto Vibes, in Hong Kong on April 14th from 6 to 10 PM HKT. The event, which will be held at 64 Jaffe Road, promises live music, scrumptious food, and unlimited drinks. LBank is proud to collaborate with LBank Labs and Encryptus as sponsors for the occasion. This is the perfect opportunity for attendees to connect with crypto-native leaders, operators, builders, institutions, and investors from the most innovative and creative organizations in the ecosystem.

Overall, LBank is excited to participate in this global gathering of Web3 professionals, and looks forward to joining discussions aimed at advancing the development and adoption of Web3 technologies. As a leader in the cryptocurrency exchange industry, LBank is committed to exploring new opportunities and partnerships that will benefit the entire blockchain ecosystem.

About LBank

LBank is a global top cryptocurrency exchange founded in 2015 for buying, selling, receiving and storing Bitcoin and other digital currencies. It provides its 9 million+ users with a secure trading platform and the lowest transaction fees.

The platform supports more than 800 trading pairs and 149+ fiat currencies. It offers services around crypto trading, specialized financial derivatives, and professional asset management services.

Start Trading Now: Ibank.com

Community & Social Media:

lTelegram

lTwitter

lFacebook

lLinkedin

Contact Details:

LBK Blockchain Co. Limited
press@lbank.info

SOURCE: LBank

Vivid Sydney 2023 Serves Up Biggest Program Yet

SYDNEY, AUSTRALIA / ACCESSWIRE / April 05, 2023 / Vivid Sydney will deliver the biggest and most culturally relevant program in its event history when it returns in 2023 from Friday 26 May to Saturday 17 June.Lighting of the Sails – Vivid Sydney – Sydney Opera House Australia’s largest event and the pioneer of light-based […]

SYDNEY, AUSTRALIA / ACCESSWIRE / April 05, 2023 / Vivid Sydney will deliver the biggest and most culturally relevant program in its event history when it returns in 2023 from Friday 26 May to Saturday 17 June.Lighting of the Sails – Vivid Sydney – Sydney Opera House

Australia’s largest event and the pioneer of light-based art and culture festivals in the Asia-Pacific region has assembled some of the world’s most innovative artists, talented music makers and thought leaders as part of its 2023 lineup, which also recognises the significant contribution of First Nations peoples and cultures to the creative industries.

Inspired by the master of all creators, Mother Nature, this year’s theme, “Vivid Sydney, Naturally,” is reflected across all of the 300+ activations and events that make up the 23-day program.

Vivid Sydney Light Walk’s signature Sydney Opera House Lighting of the Sails will see the vibrant works of one of Australia’s most famed artists, John Olsen , brought to life as a spectacular tribute to his illustrious artistic career of more than 60 years. Life Enlivened (2023) will include Olsen’s evocative Salute to Five bells (1971-73) mural commissioned especially for the Northern Foyer of Sydney Opera House’s Concert Hall, as well as other artworks spotlighting Olsen’s fascination with Australian landscapes and nature.

The Vivid LIVE at Sydney Opera House lineup will feature more than 40 Australian and international artists. José González , Yaeji , Ella Mai , Cat Power , Devonté Hynes and many more will take to the stages of the world-famous building in a program curated by Sydney Opera House’s Head of Contemporary Music Ben Marshall .

The Vivid Music program will spotlight First Nations and Australian voices this year. The late Archie Roach AC will be celebrated with an incredible night of performances with the late artist’s longtime friends and collaborators and special appearances by members of Roach’s family. There will also be 12 nights of free music at Tumbalong Park , Darling Harbour featuring Yothu Yindi , Dan Sultan , cult Japanese artist Cornelius and many more.

British author and “master of her material” Jeanette Winterson features at Vivid Ideas and will reflect on questions of identity, sexuality, religion and more to unpack the idea of nature in LIFE AND MARS: The Future of Human .

And for the first time, Vivid Sydney’s brand-new pillar – Vivid Food – will broaden the creative spotlight from Light, Music and Ideas to include culinary favourites and innovative food events. Work up an appetite for a fusion of street food; a barbecue of epic proportions with legendary pitmasters for Vivid Fire Kitchen at the Cutaway at Barangaroo; fine-dining experiences; and the return of 2022’s sell-out Vivid Sydney Dinner at the Ivy Ballroom, a special feast by esteemed Sydney chefs Ben Greeno and Danielle Alvarez .

Vivid Sydney Festival Director Gill Minervini said Vivid Sydney has come of age and has evolved into a progressive and inclusive event that celebrates the best of an expanded definition of the creative industries in 2023.

“Vivid Sydney is the original festival of light, art and culture. 2023 is the 13th time it has been staged and so it has naturally evolved over time to ensure that it stays relevant to the creative industries and what that means to people today,” Minervini said.

“We are truly proud of this year’s program. We have raised the bar on the size and scale of the events and activated new parts of the city. Our lineup features more diverse talent across more industries.

“There are world-firsts and festival-firsts, and both free and ticketed events to make the festival accessible to everyone. Audiences should be prepared to be blown away by the calibre of talent and a program that has been inspired by the beauty and diversity of nature.

“Vivid Sydney’s 2023 program is a celebration of authenticity, an invitation to connect, and a chance to create. You do not want to miss Vivid Sydney 2023.”

Destination NSW CEO Steve Cox said Vivid Sydney was the biggest and most loved annual event in the NSW calendar that, in 2023, would once again support the entire ecosystem of the state’s visitor economy. “Each year, visitors and Sydneysiders immerse themselves in the program and enjoy the activations of the talented creatives who make the festival so special. Last year we welcomed a record 2.58 million attendees across the festival footprint,” Cox said.

“Vivid Sydney 2022 injected $119 million into the NSW visitor economy. It is our expectation that with its expanded program and more international travellers returning to our shores, Vivid Sydney 2023 will drive even greater visitor expenditure into the NSW economy.”

Staged across Sydney’s city centre, Vivid Sydney festival locations include Circular Quay, the Sydney Opera House, The Rocks, Walsh Bay, Barangaroo, King Street Wharf, Darling Harbour, Darling Quarter, Darling Square, The Goods Line, Central Station, the Royal Botanic Garden Sydney, Carriageworks, Taronga Zoo and more.

MEDIA ASSETS

The full 2023 Vivid Sydney media kit, program announcement and high-res imagery, including 2023 Vivid Sydney light renders and broadcast-quality video footage of previous festival highlights, are available to download at www.vividsydney.com/news-room .

MEDIA CONTACTS

Greg Vekiarellis , Ogilvy PR
PH: +61 401 873 217
greg.vekiarellis@ogilvy.com.au

Jenna Whyte , Destination NSW
PH: +61 484 719 536
jenna.whyte@dnsw.com.au

ABOUT VIVID SYDNEY

Vivid Sydney is Australia’s largest festival celebrating creativity, innovation and technology, and transforms Sydney into a kaleidoscope of colour and events for 23 nights. Staged for its 13th year in 2023, Vivid Sydney will bring together mesmerising displays from the world’s brightest light artists, exhilarating live music performances, deep-dive discussions with thought leaders, and innovative experiences from food creatives. Vivid Sydney is owned, managed and produced by Destination NSW, the NSW Government’s tourism and major events agency.

Contact Information

Jenna Whyte
PR Manager
jenna.whyte@dnsw.com.au

Related Files

Med Rel_Vivid Sydney 2023 serves up biggest program yet.pdf

Related Video

https://vimeo.com/807364026/acbc4fe650

SOURCE: Vivid Sydney

Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility

Facility to enable access to manufactured mRNA vaccines for Kenya and the African continent, providing health security and building upon Moderna’s global public health commitments The facility will be capable of producing up to 500 million doses each year CAMBRIDGE, MA & NAIROBI, KENYA/ ACCESSWIRE / March 30, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology […]

Facility to enable access to manufactured mRNA vaccines for Kenya and the African continent, providing health security and building upon Moderna’s global public health commitments

The facility will be capable of producing up to 500 million doses each year

CAMBRIDGE, MA & NAIROBI, KENYA/ ACCESSWIRE / March 30, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya. This will be the Company’s first mRNA manufacturing facility in Africa.

In partnership with the Government of the Republic of Kenya, Moderna will build a state-of-the-art mRNA facility in Kenya to produce up to 500 million doses of vaccines each year. The Company expects the new facility to enable drug substance and drug product manufacturing for Kenya and the African continent. In addition, this facility will have surge capacity to rapidly scale and respond to public health emergencies on the continent and around the world.

“The finalization of our agreement with the Government of the Republic of Kenya is a key pillar of our global public health strategy, where we hope to bring mRNA innovation to the people of Africa in areas of high unmet need, such as acute respiratory infections, as well as persistent infectious diseases like HIV and outbreak threats such as Zika and Ebola,” said Stéphane Bancel, Chief Executive Officer of Moderna. “This also demonstrates our confidence in the investment climate in Kenya and the importance of utilizing mRNA technology to build resilience in healthcare security in Africa. We are also grateful for the leadership of the U.S. Ambassador to Kenya, Meg Whitman, and Samantha Power, in her role as Administrator of the United States Agency for International Development for their instrumental support of this project.”

“We are excited about this milestone that brings to bear our efforts as Government to sustain our economic model of facilitating investments that serve not only Kenya but the African continent. My Government commits to supporting this investment as a critical signal to the investment community that Kenya is open for business,” said President William Ruto.

“This investment creates the momentum to meet the $10 billion annual target under the Government’s manufacturing 20 by 30 vision, where we plan to grow the contribution of manufacturing to GDP to 20% by the year 2030 from the current 7%,” said Kenya’s Cabinet Secretary for Investments, Trade, and Industry Hon. Moses Kuria.

The Government of Kenya has championed an accelerated investment agenda to grow foreign direct investment levels from the current levels of $448 million annually to $10 billion annually, making the country’s goal the continent’s most ambitious agenda to attract investments as an enabler to job creation. Moderna’s investment signifies confidence in the business environment in Kenya and readiness to support foreign and local investment in the healthcare sector, as well as Moderna’s ongoing commitment to global public health. Moderna will operate under a Special Economic Zone (SEZ) status, signifying Kenya’s increasing focus on the SEZ program as a key enabler of economic growth.

With this agreement, Moderna has commitments to establish mRNA manufacturing facilities in Kenya, the United States, Canada, Australia, and the United Kingdom, furthering health security around the world. Moderna has spent more than a decade refining its mRNA platform to accelerate the pace and success of mRNA medicines. The speed, scale, and flexibility of Moderna’s mRNA platform is uniquely suited for rapid response to serious international epidemics, commonly referred to as Disease X.[i]

Moderna is committed to advancing into clinical studies a portfolio of 15 vaccine programs targeting emerging or neglected infectious diseases by 2025, advancing vaccines that address current diseases of significant impact to low- and middle-income countries, and those that prepare for Disease X. Moderna will prioritize development efforts against pathogens identified as persistent global health threats, including HIV, tuberculosis (TB) and malaria, neglected tropical diseases and the priority pathogens of the World Health Organization and the Coalition for Epidemic Preparedness Innovations. Learn more at https://www.modernatx.com/responsibility/our-commitment.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio, and integrated manufacturing facilities that allow for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID pandemic.

Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past eight years. To learn more, visit www.modernatx.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the Company’s plans to build an mRNA manufacturing facility in Kenya; the anticipated capacity and output for that facility; the ability of the facility to respond to public health emergencies; Moderna’s aspiration to develop treatments or vaccines against HIV, Zika, Ebola, and other public health pathogens; the ability of Moderna’s mRNA platform to respond to future epidemics; foreign investment in the health sector in Kenya; the advantages of doing business in a Kenyan Special Economic Zone; and Moderna’s plans to establish manufacturing facilities in the United State, Canada, United Kingdom, and Australia. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission (SEC), which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts:

Media:

Luke Mircea Willats
Senior Director, Corporate Communications
Luke.Mirceawillats@modernatx.com

Investors:

Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

[i] “Disease X” was named by the WHO to represent the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts

SOURCE: Moderna, Inc.

Bodog Launches Casino Operations in Regulated Isle of Man

New Bodog.io casino platform to exclusively accept cryptocurrency payments via Isle of Man license DOUGLAS, ISLE of MAN / ACCESSWIRE / March 22, 2023 / Leading online casino Bodog today announces that it has acquired an all-new gambling license in the Isle of Man in the wake of launching its new casino-only platform, Bodog.io. Designed […]

New Bodog.io casino platform to exclusively accept cryptocurrency payments via Isle of Man license

DOUGLAS, ISLE of MAN / ACCESSWIRE / March 22, 2023 / Leading online casino Bodog today announces that it has acquired an all-new gambling license in the Isle of Man in the wake of launching its new casino-only platform, Bodog.io. Designed exclusively for cryptocurrency wagers, Bodog.io is an excellent option for players seeking fast and secure transactions.

Having been awarded this license from The Isle of Man Gambling Commission, Bodog is now in a position to expand casino operations in more territories under favorable regulation, with a new site, under the same trusted brand name existing since 1994.

“We are thrilled to have secured our license in the Isle of Man ahead of the Bodog.io launch,” said a spokesperson for Bodog. “Our team has worked hard to create a crypto-native online casino that provides players with a safe, secure, and fun gaming experience. We are confident that our players will enjoy the platform as we aim to uphold our commitment to safe and responsible gambling as we do with all our brands.”

The Isle of Man Gambling Supervision Commission (GSC) is known globally for ensuring operators are in full compliance with all regulations and is committed to effective regulatory oversight of the online gambling industry.

Founded in 1994, Bodog has become one of the most widely known online casinos in the industry. With around-the-clock customer service available to players, as well as various features such as crypto wagering and play in mBTC, players from all over the world prefer Bodog as their reliable gaming partner. Under the Bodog.io webpage regulated by Isle of Man and operated by Star Jar (IOM) Ltd, the company’s focus on crypto-exclusive casino games on a user-friendly platform will add to its reputation for cutting-edge projects.

About Bodog

Founded in 1994, Bodog is considered an industry leader, providing players with a world-class, full Vegas-style casino. Bodog’s Customer Service team is available 24/7 and dedicated to making sure sessions go off without a hitch. For more information, please visit bodog.io

Contact:

Kyle Smith
Bodog Communications Director
Email: bodogpress@gmail.com

SOURCE: Bodog

 

Bodog Launches Casino Operations in Regulated Isle of Man New Bodog.io casino platform to exclusively accept cryptocurrency payments via Isle of Man license DOUGLAS, ISLE of MAN / ACCESSWIRE / March 22, 2023 / Leading online casino Bodog today announces that it has acquired an all-new gambling license in the Isle of Man in the wake of launching its new casino-only platform, Bodog.io. Designed exclusively for cryptocurrency wagers, Bodog.io is an excellent option for players seeking fast and secure transactions. Having been awarded this license from The Isle of Man Gambling Commission, Bodog is now in a position to expand casino operations in more territories under favorable regulation, with a new site, under the same trusted brand name existing since 1994. “We are thrilled to have secured our license in the Isle of Man ahead of the Bodog.io launch,” said a spokesperson for Bodog. “Our team has worked hard to create a crypto-native online casino that provides players with a safe, secure, and fun gaming experience. We are confident that our players will enjoy the platform as we aim to uphold our commitment to safe and responsible gambling as we do with all our brands.” The Isle of Man Gambling Supervision Commission (GSC) is known globally for ensuring operators are in full compliance with all regulations and is committed to effective regulatory oversight of the online gambling industry. Founded in 1994, Bodog has become one of the most widely known online casinos in the industry. With around-the-clock customer service available to players, as well as various features such as crypto wagering and play in mBTC, players from all over the world prefer Bodog as their reliable gaming partner. Under the Bodog.io webpage regulated by Isle of Man and operated by Star Jar (IOM) Ltd, the company’s focus on crypto-exclusive casino games on a user-friendly platform will add to its reputation for cutting-edge projects. About Bodog Founded in 1994, Bodog is considered an industry leader, providing players with a world-class, full Vegas-style casino. Bodog’s Customer Service team is available 24/7 and dedicated to making sure sessions go off without a hitch. For more information, please visit bodog.io Contact: Kyle Smith Bodog Communications Director Email: bodogpress@gmail.com SOURCE: Bodog

New Bodog.io casino platform to exclusively accept cryptocurrency payments via Isle of Man license DOUGLAS, ISLE of MAN / ACCESSWIRE / March 22, 2023 / Leading online casino Bodog today announces that it has acquired an all-new gambling license in the Isle of Man in the wake of launching its new casino-only platform, Bodog.io. Designed […]

New Bodog.io casino platform to exclusively accept cryptocurrency payments via Isle of Man license

DOUGLAS, ISLE of MAN / ACCESSWIRE / March 22, 2023 / Leading online casino Bodog today announces that it has acquired an all-new gambling license in the Isle of Man in the wake of launching its new casino-only platform, Bodog.io. Designed exclusively for cryptocurrency wagers, Bodog.io is an excellent option for players seeking fast and secure transactions.

Having been awarded this license from The Isle of Man Gambling Commission, Bodog is now in a position to expand casino operations in more territories under favorable regulation, with a new site, under the same trusted brand name existing since 1994.

“We are thrilled to have secured our license in the Isle of Man ahead of the Bodog.io launch,” said a spokesperson for Bodog. “Our team has worked hard to create a crypto-native online casino that provides players with a safe, secure, and fun gaming experience. We are confident that our players will enjoy the platform as we aim to uphold our commitment to safe and responsible gambling as we do with all our brands.”

The Isle of Man Gambling Supervision Commission (GSC) is known globally for ensuring operators are in full compliance with all regulations and is committed to effective regulatory oversight of the online gambling industry.

Founded in 1994, Bodog has become one of the most widely known online casinos in the industry. With around-the-clock customer service available to players, as well as various features such as crypto wagering and play in mBTC, players from all over the world prefer Bodog as their reliable gaming partner. Under the Bodog.io webpage regulated by Isle of Man and operated by Star Jar (IOM) Ltd, the company’s focus on crypto-exclusive casino games on a user-friendly platform will add to its reputation for cutting-edge projects.

About Bodog

Founded in 1994, Bodog is considered an industry leader, providing players with a world-class, full Vegas-style casino. Bodog’s Customer Service team is available 24/7 and dedicated to making sure sessions go off without a hitch. For more information, please visit bodog.io

Contact:

Kyle Smith
Bodog Communications Director
Email: bodogpress@gmail.com

SOURCE: Bodog